Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hyperlipidemias: full-pipeline trial registry
6 of 22 indexed Hyperlipidemias trials are currently recruiting.
Corpus placement: #756 of 28,707 conditions by registered trial count.
22 US clinical trials · 6 currently recruiting · #756 of 28,707 conditions by registered trial count
Hyperlipidemias: 22 US clinical trials tracked, 6 recruiting.
Hyperlipidemias is the subject of 22 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 2 of these trials.
Enrollment posture brief
Registry condition hyperlipidemias
OPEN 6 | RECR 27% | LATE 2 | EARLY 3 | RANK #756 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Atherosclerotic Cardiovascular Disease (27% recruiting · 22 trials)
Hyperlipidemias lists 6 open slots (27% of 22 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hyperlipidemias on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hyperlipidemias is recruiting below its size-band peers.
6 of 22 indexed trials (27.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hyperlipidemias trials is spread across many organizations.
Johns Hopkins University accounts for 2 of 22 trials (9.1%). 20 distinct sponsors appear on at least one study for this condition label.
-
Typical Hyperlipidemias enrolment sits around 87 participants.
Median target enrolment is 87 among the 22 trials that report a genuine target (sentinel values excluded). 13 of those (59.1%) plan for fewer than 100 participants.
-
Hyperlipidemias research is mostly interventional.
20 interventional and 2 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
22 total, page 1 of 1
Social Needs Screening and Chronic Diseases Study (WE CARE)
University of Massachusetts, Worcester
NCT06903897
Penn Medicine Healthy Heart
University of Pennsylvania
NCT06062394
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
Ohio State University
NCT06055036
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
West Virginia School of Osteopathic Medicine
NCT06049420
Imaging the Pathogenesis of Cerebral Small Vessel Disease
Johns Hopkins University
NCT05703386
Bempedoic Acid Pregnancy Surveillance Program
Esperion Therapeutics
NCT05103254
Centralized Prescribing for Statins
University of Pennsylvania
NCT05537064
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Johns Hopkins University
NCT06347484
Virtual Diabetes Group Visits Across Health Systems
University of Chicago
NCT06094491
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
Rutgers, The State University of New Jersey
NCT06461273
Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications
University of Colorado, Denver
NCT03973931
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
Case Western Reserve University
NCT03643705
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Kastle Therapeutics
NCT00694109
Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors
Phoenix VA Health Care System
NCT03330548
Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
Silence Therapeutics
NCT04606602
Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children
Poudre Valley Health System
NCT01911390
Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers
Tufts University
NCT00175084
Effects of Psyllium on Niacin Tolerability
VA Greater Los Angeles Healthcare System
NCT03370848
Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI)
Oregon Health and Science University
NCT04036773
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
Catabasis Pharmaceuticals
NCT01968720
The Mixed Meal Challenge Study
Emory University
NCT05087823
Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness
Katherine Vickery
NCT06025721
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hyperlipidemias records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hyperlipidemias trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hyperlipidemias page
22 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Hyperlipidemias trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Johns Hopkins University sponsors the most Hyperlipidemias trials on record, review their full trial history before evaluating a specific study. See Johns Hopkins University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hyperlipidemias condition card totals 22 registered trials; most-linked intervention Placebo; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.